Rankings
▼
Calendar
DNA Q2 2020 Earnings — Ginkgo Bioworks Holdings, Inc. Revenue & Financial Results | Market Cap Arena
DNA
Ginkgo Bioworks Holdings, Inc.
$412M
Q2 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$10M
Gross Profit
$10M
100.0% margin
Operating Income
-$31M
-305.6% margin
Net Income
-$29M
-282.0% margin
EPS (Diluted)
$-0.94
QoQ Revenue Growth
-51.9%
Cash Flow
Operating Cash Flow
-$27M
Free Cash Flow
-$34M
Stock-Based Comp.
$117,000
← FY 2020
All Quarters
Q3 2020 →
